- €722.25m
- €1.24bn
- €919.81m
- 48
- 93
- 64
- 81
2019 December 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 3 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 312 | 70.1 | 672 | 766 | 920 |
Cost of Revenue | |||||
Gross Profit | 74.5 | 20 | 175 | 203 | 221 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 258 | 62.7 | 544 | 621 | 762 |
Operating Profit | 54.1 | 7.47 | 128 | 144 | 158 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 44.5 | 3.03 | 114 | 125 | 137 |
Provision for Income Taxes | |||||
Net Income After Taxes | 34.1 | 3.31 | 85.1 | 93.9 | 105 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 31.6 | 3.16 | 85.1 | 93.1 | 105 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 31.6 | 3.16 | 85.1 | 93.1 | 105 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.658 | 0.068 | 1.82 | 2.01 | 2.12 |
Dividends per Share |